Pharmaceutical Executive February 24, 2020
Approximately one in 25 adults in the U.S. experience serious mental illness; and globally around 450 million people live with mental health disorders, which are among the leading causes of ill-health and disability worldwide. The World Health Organization (WHO) has focused international attention on this major societal problem through its Mental Health Action Plan 2013 – 2020 and set a goal of accelerated implementation of the WHO Special Initiative for Mental Health through 2023. We will continue to see an ever-increasing need for the advancement of policies, advocacy, and integrated services for people living with mental health conditions. Coupled with significant progress in science and medicine, including in the diagnosis and treatment of mental illnesses, we hope to see meaningful...
Today's Sponsors
Today's Sponsor